Back to top
more

Becton, Dickinson and Company (BDX)

(Delayed Data from NYSE)

$237.84 USD

237.84
1,032,669

+0.54 (0.23%)

Updated Jul 29, 2024 04:00 PM ET

After-Market: $237.77 -0.07 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

Becton Dickinson (BDX) Meets Q1 Earnings Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 0.00% and -0.05%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Cardinal Health's (CAH) Q2 Earnings?

Cardinal Health (CAH) likely to gain from solid Pharmaceutical revenues in fiscal Q2; medical-gloves sub-segment likely to be soft.

AmerisourceBergen (ABC) Jumps: Stock Rises 6.2%

AmerisourceBergen (ABC) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Can Molecular Diagnostics Drive Myriad's (MYGN) Q2 Earnings?

Myriad (MYGN) likely to deliver solid Q2 results on the diversified Molecular Diagnostics portfolio with products like GeneSight, EndoPredict, BRACAnalysis CDx and Prolaris tests.

Why the Earnings Surprise Streak Could Continue for Becton Dickinson (BDX)

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Varian Strong on Global Expansion and Proton Therapy Arm

Varian's (VAR) strong presence in China instills optimism in the stock.

Becton Dickinson (BDX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can BD Medical Drive Becton, Dickinson's (BDX) Q1 Earnings?

Becton, Dickinson's (BDX) solid fiscal first-quarter preliminary results boost optimism in the stock.

Accuray's (ARAY) Q2 Loss Narrows, Radixact Demand Shoots Up

Demand for flagship Radixact & CyberKnife platforms aids Accuray's (ARAY) fiscal Q2 results.

CONMED (CNMD) Q4 Earnings Match Estimates, Revenues Beat

CONMED's (CNMD) Q4 results get a boost from solid segmental performances.

Here's Why Investors Should Bet on Abiomed (ABMD) Stock Now

Strong contribution from Impella product line is likely to provide Abiomed (ABMD) a competitive edge in the MedTech space.

Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Becton, Dickinson and Company, ArcBest, Tetra Tech and Nexstar Media

Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Becton, Dickinson and Company, ArcBest, Tetra Tech and Nexstar Media

Sweta Killa headshot

5 Cheap Dividend Stocks That Offer Growth

Amid heightened volatility and uncertainty, investors are looking for both income and growth in their portfolio. As a result, picking dividend growth stocks appear as a winning strategy.

Here's Why Investors Should Hold AngioDynamics (ANGO) Now

AngioDynamics' (ANGO) flagship NanoKnife System is currently witnessing robust demand.

Cerner Picked by Remi Vista for Behavioral Health Technology

Apart from Cerner Integrated, Cerner's (CERN) revenue cycle solutions will help Remi Vista's financial operations.

Here's Why Investors Should Retain athenahealth (ATHN) Stock

athenahealth (ATHN) gains from a broad product portfolio. However, it faces stiff competition in the MedTech space.

Allscripts Selected by Premier for Connected Health Platform

Premier Orthopaedics will leverage on Allscripts' (MDRX) Professional EHR, Practice Management software, FollowMyHealth and Payerpath suite of solutions.

Cerner (CERN) Teams Up With Nebraska-Based LRHC, Shares Up

Cerner's (CERN) coveted Millennium platform has seen rising demand in recent times.

Here's Why You Should Invest in OPKO Health (OPK) Right Now

OPKO Health's (OPK) flagship RAYALDEE lends it a competitive edge in the MedTech space.

Becton, Dickinson's MAX Enteric Viral Panel Cleared by FDA

Becton, Dickinson's (BDX) Diagnostic Systems portfolio lends it a competitive edge.

Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

Plethora of developments for Becton, Dickinson (BDX); headwinds apprehended in fiscal 2019.

BD Gets Enterprise Level Cybersecurity Assessment From UL

BD (BDX) receives UL CAP for BD FACSLyric flow cytometer with BD FACSuite Clinical software.

Why Is Becton Dickinson (BDX) Up 3.4% Since Last Earnings Report?

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Stock Market News For Nov 30, 2018

Wall Street ended lower on Thursday as investors closely watched the G-20 summit in Argentina where President Donald Trump is scheduled to discuss trade issues with his Chinese counterpart Xi Jinping

BD Brings HealthSight Diversion App to Combat Opioid Crisis

BD's (BDX) latest development is likely to boost the company's Medication Management unit.